Influenza vaccination in children primed with MF59(®)-adjuvanted or non-adjuvanted seasonal influenza vaccine

Por Vesikari, Timo, Forstén, Aino, Arora, Ashwani, Tsai, Theodore, Clemens, Ralf
Publicado no Hum Vaccin Immunother (2015)

A dose-ranging study of MF59(®)-adjuvanted and non-adjuvanted A/H1N1 pandemic influenza vaccine in young to middle-aged and older adult populations to assess safety, immunogenicity...

Por Reisinger, Keith S, Holmes, Sandra J, Pedotti, Paola, Arora, Ashwani Kumar, Lattanzi, Maria
Publicado no Hum Vaccin Immunother (2014)

Comparison of the immunogenicity and safety of the purified chick embryo cell rabies vaccine manufactured in India and Germany: A randomized, single blind, multicentre, phase IV cl...

Por Sampath, Gadey, Banzhoff, Angelika, Deshpande, Alaka, Malerczyk, Claudius, Arora, Ashwani Kumar, Vakil, Hoshang, Preiss, Scott
Publicado no Hum Vaccin Immunother (2017)

Safety and immunogenicity of meningococcal ACWY CRM(197)-conjugate vaccine in children, adolescents and adults in Russia

Por Ilyina, Natalia, Kharit, Susanna, Namazova-Baranova, Leila, Asatryan, Asmik, Benashvili, Mayya, Tkhostova, Elmira, Bhusal, Chiranjiwi, Arora, Ashwani Kumar
Publicado no Hum Vaccin Immunother (2014)

Safety and immunogenicity of a meningococcal B recombinant vaccine when administered with routine vaccines to healthy infants in Taiwan: A phase 3, open-label, randomized study

Por Chiu, Nan-Chang, Huang, Li-Min, Willemsen, Arnold, Bhusal, Chiranjiwi, Arora, Ashwani Kumar, Reynoso Mojares, Zenaida, Toneatto, Daniela
Publicado no Hum Vaccin Immunother (2018)

Immunogenicity and safety of cell-derived MF59®-adjuvanted A/H1N1 influenza vaccine for children

Por Knuf, Markus, Leroux-Roels, Geert, Rümke, Hans, Rivera, Luis, Pedotti, Paola, Arora, Ashwani Kumar, Lattanzi, Maria, Kieninger, Dorothee, Cioppa, Giovanni Della
Publicado no Hum Vaccin Immunother (2015)

MF59-adjuvanted influenza vaccine (FLUAD®) elicits higher immune responses than a non-adjuvanted influenza vaccine (Fluzone®): A randomized, multicenter, Phase III pediatric trial...

Por Cruz-Valdez, Aurelio, Valdez-Zapata, Gabriel, Patel, Sanjay S., Castelli, Flavia V., Garcia, Marcia G., Jansen, Wim T., Arora, Ashwani Kumar, Heijnen, Esther
Publicado no Hum Vaccin Immunother (2018)

Shortening intradermal rabies post-exposure prophylaxis regimens to 1 week: Results from a phase III clinical trial in children, adolescents and adults

Por Kerdpanich, Phirangkul, Chanthavanich, Pornthep, De Los Reyes, Mari Rose, Lim, Jodor, Yu, Delia, Ama, Ma. Cecilia, Mojares, Zenaida, Casula, Daniela, Arora, Ashwani Kumar, Pellegrini, Michele
Publicado no PLoS Negl Trop Dis (2018)

Comparative study on the immunogenicity and safety of a purified chick embryo cell rabies vaccine (PCECV) administered according to two different simulated post exposure intramuscu...

Por Mahendra, BJ, Narayana, DH Ashwath, Agarkhedkar, Sharad, Ravish, HS, Harish, BR, Agarkhedkar, Shalaka, Madhusudana, SN, Belludi, Ashwin, Ahmed, Khaleel, Jonnalagedda, Rekha, Vakil, Hoshang, Bhusal, Chiranjiwi, Arora, Ashwani Kumar
Publicado no Hum Vaccin Immunother (2015)